tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
GSK and Spero Therapeutics: Phase 3 Study Completion on Oral vs. IV UTI Treatment
PremiumCompany AnnouncementsGSK and Spero Therapeutics: Phase 3 Study Completion on Oral vs. IV UTI Treatment
4M ago
Spero Therapeutics Increases Stock Incentive Plan Shares
Premium
Company Announcements
Spero Therapeutics Increases Stock Incentive Plan Shares
4M ago
Largest borrow rate increases among liquid names
Premium
The Fly
Largest borrow rate increases among liquid names
5M ago
GSK reports PIVOT-PO study for tebipenem HBr stopped early for efficacy
PremiumThe FlyGSK reports PIVOT-PO study for tebipenem HBr stopped early for efficacy
5M ago
Spero Therapeutics, GSK announce Phase 3 PIVOT-PO trial met primary endpoint
Premium
The Fly
Spero Therapeutics, GSK announce Phase 3 PIVOT-PO trial met primary endpoint
5M ago
Spero Therapeutics Reports Q1 2025 Results and Updates
Premium
Company Announcements
Spero Therapeutics Reports Q1 2025 Results and Updates
5M ago
Spero Therapeutics reports Q4 EPS (38c), consensus (31c)
PremiumThe FlySpero Therapeutics reports Q4 EPS (38c), consensus (31c)
7M ago
SPRO Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
SPRO Earnings Report this Week: Is It a Buy, Ahead of Earnings?
7M ago
Citizens JMP healthcare analysts hold an analyst/industry conference call
Premium
The Fly
Citizens JMP healthcare analysts hold an analyst/industry conference call
8M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100